Market Dynamics
For a long time, the Indian population that had faced nutrition is now vulnerable to nutrition and sedentary lifestyles. Combined with a low dietary background and the fact that, relative to other demographic groups, Indians are genetically more vulnerable to diabetes, the battle against diabetes in India is projected to be one of the largest epidemics the nation has ever faced. The main causes of diabetes in India are elevated obesity rates, increased levels of stress and lack of regular exercise. The Indian Government is taking steps to provide free care and insulin to diabetics at government hospitals in order to monitor the harm caused by the growing cases of diabetes in the region. Growing consumer understanding of the signs of diabetes and its adverse health consequences has largely improved the country's diagnosis and opioid treatment rates. This is the biggest growth driving force for India's diabetes industry.
Free Sample Copy of With Considering Coivd19 Impact on this Market @ https://www.marketresearchfuture.com/sample_request/5507
Rapid urbanization, the expansion of healthcare facilities, low cost drug manufacturing, the acceleration of pharmaceutical contract production and the adoption of new technologies are some of the other factors leading to demand growth. India's diabetes numbers may ring warning bells for the government and health authorities, but it is a gold mine for drug and diagnostic manufacturers. Growing visibility, increasing patient numbers, the untouched rural market, increasing urbanization, the growth of healthcare facilities and increasing healthcare spending are thus pushing India's diabetes market. However, the major factors hindering market growth are high research and development costs, rigid pricing regulations, technical advances that render current products unmarketable or expired, and regulatory approvals in terms of quality management, price control and IPR (Intellectual Property Rights) protection.
In the presence of numerous healthcare industry actors, COVID-19 faced a dynamic obstacle, which had a serious impact on the worldwide market. When patients with diabetes experience COVID-19 infection, the fluctuating blood glucose levels are more difficult to treat and it is also difficult to treat the symptoms of diabetes. In order to prevent the uninfected from that of infectious persons, the prevalent COVID-19 resulted in lockdown; this lockdown has created a tense mind for people with chronic diseases such as medication-related diabetes and diagnostic equipment. It is also very necessary for diabetic patients to maintain an accurate level of blood glucose and also to improve the immune system in order to remain healthy from infection by the virus. COVID-19 is slated to be an opportunity for diabetes treatment market, as the patients suffering from diabetes are at the greater risk of gettingCOVID-19 infection.
Market Segmentation
The Market Research Future report provides a wide segmental analysis of the India Diabetes Devices Market based on type, test, device, and treatment.
Based on type, the India diabetes market is segmented into type 1, type 2, and gestational diabetes.
Based
on test, the India diabetes market is segmented into initial glucose
challenge test, oral glucose tolerance test, fasting blood sugar test,
random blood sugar test, and others.
Based
on devices, the India diabetes market is segmented into diabetes
management devices, blood glucose monitoring devices, and others. Of
these, the diabetes management devices segment will lead the market over
the forecast period.
Based on treatment, the India diabetes market is segmented into bariatric surgery, transplantation, insulin therapy, medications, and others.
Regional Analysis
Considering the Indian diabetes industry situation, the western region is believed to be the main diabetes market. The western region has been observed to have the largest share of the Indian diabetes market due to its highly populated existence and high consumption of sugarcane and its byproducts which are grown abundantly in the region.
In addition, Indian Diabetes is also rising in the Eastern and Northern regions and is the second largest market.
On the other hand, the South Indian market is projected to raise India's diabetes rate dramatically during the forecast period. There is expected to be minimal but moderate demand growth in the central region.
Key Players
Leading
players profiled in the India diabetes market report include Ypsomed
(Switzerland), Bayer AG (Germany), Johnson & Johnson Services, Inc.
(US), Roche Diabetes Care, Inc. (US), Becton Dickinson and Company (US),
Merck & Co., Inc. (US), Novartis AG (Switzerland), Sanofi-aventis
US LLC (US), USV Private Limited (India), and Novo Nordisk A/S
(Denmark), among others.
May
2019: RDC (Roche Diabetes Care) India has unveiled a new integrated
IDMS (integrated diabetes management solution) through the launch of
“Accu-Check Instant” blood glucose monitoring system and “mySugr” app.
Both these together will create the next-generation blood glucose
monitoring system. Through this launch, the company aims in offering a
personalized, integrated, and collaborative approach to optimal therapy
for those at the risk of having diabetes or are having diabetes.
April 2019- Glenmark Pharma, renowned drug company has launched in India its anti-diabetes drug called Remogliflozin. In India, it will be commercialized under the brand names Remozen and Remo.
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Treatment Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/diabetic-lancing-device-market-5507
Related reports link:-
Lancet Pens
Agnosia Treatment
Olanzapine Trade Name
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
0 Comments